Document is current
Any future updates will be listed below
-
Authors
Mortato, Edoardo
Talamonti, Marina
Savastano, Lorenzo
Marcelli, Lorenzo
Tofani, Lorenzo
Gneo, Valerio
Marrapodi, Domenico
Ingrosso, Maria Rosa
Bianchi, Luca
Galluzzo, Marco https://orcid.org/0000-0002-3424-5175
- License Information
-
More Information
Article History
Received: 1 December 2025
Accepted: 13 February 2026
First Online: 13 March 2026
Declarations
:
: Marco Galluzzo and Marina Talamonti have served as speakers and/or consultants for AbbVie, Almirall, Eli-Lilly, Johnson & Johnson, LeoPharma, Novartis, and Sanofi outside the submitted work. Luca Bianchi has served as a speaker and consultant for AbbVie, Novartis, Johnson & Johnson, Pfizer, UCB, and LeoPharma outside the submitted work. All other authors, Edoardo Mortato, Lorenzo Savastano, Lorenzo Marcelli, Lorenzo Tofani, Valerio Gneo, Domenico Marrapodi, Maria Rosa Ingrosso, have no relevant conflicts of interest to declare.
: Institutional review board approval was waived, as data were collected as part of routine clinical practice. All patients provided written informed consent for the collection of demographic and clinical data. The study was conducted in accordance with the principles of the Declaration of Helsinki and later amendments. Data collection and management complied with all applicable laws, regulations, and guidelines concerning patient protection and privacy.
